학술논문
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
Document Type
Article
Author
Froissart, A.; Vernant, J.-P.; Buffet, M.; Malot, S.; Coppo, P.; Guidet, B.; Veyradier, A.; Poullin, P.; Provôt, F.; Schwarzinger, M.; Galicier, L.; Azoulay, E.; Mariotte, E.; Vanhille, P.; Bordessoule, D.; Rondeau, E.; Mira, J.-P.; Wynckel, A.; Clabault, K.; Choukroun, G.; Presne, C.; Pourrat, J.; Hamidou, M.
Source
In: Critical Care Medicine . (Critical Care Medicine, January 2012, 40(1):104-111)
Subject
Language
English
ISSN
00903493
15300293
15300293